Seo, S., Kim, M., Kim, R., Yeo, Y., Kim, K. L., & Suh, W. (2020). Evogliptin, a dipeptidyl peptidase-4 inhibitor, attenuates pathological retinal angiogenesis by suppressing vascular endothelial growth factor-induced Arf6 activation. Exp Mol Med.

Seo, Songyi, Mi-Kyung Kim, Ryul-I Kim, Yeongju Yeo, Koung Li Kim, and Wonhee Suh. "Evogliptin, a Dipeptidyl Peptidase-4 Inhibitor, Attenuates Pathological Retinal Angiogenesis By Suppressing Vascular Endothelial Growth Factor-induced Arf6 Activation." Exp Mol Med 2020.

Seo, Songyi, et al. "Evogliptin, a Dipeptidyl Peptidase-4 Inhibitor, Attenuates Pathological Retinal Angiogenesis By Suppressing Vascular Endothelial Growth Factor-induced Arf6 Activation." Exp Mol Med 2020.